Sign In
Buy DBVT
$13.63
-0.230 (-1.66%)
At Close: Jul 24, 2026
DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript
10:03pm, Tuesday, 30'th Jul 2024
DBV Technologies S.A. (NASDAQ:DBVT ) Q2 2024 Earnings Conference Call July 30, 2024 5:30 PM ET Company Participants Katie Matthews – Investor Relations Daniel Tassé – Chief Executive Officer Phar
DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
05:30pm, Tuesday, 30'th Jul 2024
Châtillon, France, July 30, 2024 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR001041734
Châtillon, France, July 30, 2024 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results VITESSE enrol
DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
01:30am, Monday, 29'th Jul 2024
Châtillon, France, July 29, 2024 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasda
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
04:30pm, Monday, 08'th Jul 2024
AMF Regulated Information Montrouge, France, July 8, 2024 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq St
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
04:30pm, Wednesday, 05'th Jun 2024
Châtillon, France, June 5, 2024 DBV Technologies to Participate in the Goldman Sachs 45 th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock
DBV Technologies Announces Plan to Implement ADS Ratio Change
09:51am, Friday, 31'st May 2024
Châtillon, France, May 31, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101),
DBV Technologies to Participate in Upcoming EAACI 2024 Congress
04:30pm, Thursday, 30'th May 2024
Châtillon, France, May 30, 2024 DBV Technologies to Participate in Upcoming EAACI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
DBV Technologies Announces Plan to Implement ADS Ratio Change
04:30pm, Friday, 17'th May 2024
Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101),
DBV Technologies Announces Results of its 2024 Combined General Meeting
04:30pm, Thursday, 16'th May 2024
Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010
DBV Technologies to Participate in Upcoming Investor Conferences
04:30pm, Thursday, 09'th May 2024
Montrouge, France, May 9, 2024 DBV Technologies to Participate in Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
04:30pm, Tuesday, 07'th May 2024
Montrouge, France, May 7, 2024 DBV Technologies Reports First Quarter 2024 Financial Results and Business Update VITESSE enrollment on track to screen last patient by Q3 2024 Appointment of Robert Pie
Combined General Meeting of May 16, 2024
04:30pm, Thursday, 25'th Apr 2024
Châtillon, France, April 25, 2024 Combined General Meeting of May 16, 2024 Procedures for Obtaining Information and Preparatory Documents for the Combined General Meeting DBV Technologies (Euronext:
DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document
09:33am, Friday, 08'th Mar 2024
Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nas
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
04:30pm, Thursday, 07'th Mar 2024
Montrouge, France, March 7, 2024 DBV Technologies Reports Full Year 2023 Financial Results and Business Update Advanced Viaskin™ Peanut clinical development programs in peanut-allergic toddlers (1 t
